Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK2) in postmenopausal RA patients

Modern Rheumatology

Volumn 23, Issue 3, 2013, Pages 450-455

  Suzuki, Kouji ^a   Tsuji, Shigeyoshi ^a   Fukushima, Yaeko ^b   Nakase, Takanobu ^a   Hamada, Masayuki ^a   Tomita, Tetsuya ^c   Yoshikawa, Hideki ^c  

^a HOSHIGAOKA KOSEINENKIN HOSPITAL   (Japan)

^b Seikeikai Hospital   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alendronate (ALN); Menatetrenone (VitK2); Osteoporosis; Rheumatoid arthritis (RA); Undercarboxylated osteocalcin (ucOC)

Indexed keywords

ALBUMIN; ALENDRONIC ACID; ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; C REACTIVE PROTEIN; CALCIUM; COLLAGEN TYPE 1; MENATETRENONE; OSTEOCALCIN; PHOSPHORUS; PREDNISOLONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SERUM ALBUMIN; VITAMIN D;

AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; FEMALE; FEMUR NECK FRACTURE; FOLLOW UP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MONOTHERAPY; OPEN STUDY; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SPINE FRACTURE; THERAPY EFFECT;

AGED; ALENDRONATE; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAMIN K 2;

EID: 84877726078     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0678-x     Document Type: Article

References (14)

1. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum. 2000;43:522-30.
2. Van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54:3104-12.
3. No authors listed. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement. 2000;17:1-45.
4. Sorensen OH, Crawford GM, Mulder H, Hosking DJ, Gennari C, Mellstrom D, et al. Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience. Bone. 2003;32:120-6.
5. Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, et al. Ten year's experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med. 2004;350:1189-99.
6. Feskanich D, Weber P, Willet WC, Rockett H, Booth SL, Colditz GA. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr. 1999;69:74-9.
7. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137-48.
8. Yilmaz L, Ozoran K, Gündüz OH, Uçan H, Yücel M. Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids. Rheumatol Int. 2001;20:65-9.
9. Eastell R, Devogelaer JP, Peel NF, Chines AA, Bax DE, Sacco-Gibson N, et al. Prevention of loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients. Osteoporos Int. 2000;11:331-7.
10. Kai M, Makino S, Yuasa M, Nishijima T. Study of bone vitamin K deficiency of RA patients-Evaluation with the measurement of ucOC in serum. Rheumatology.2009;42:133-8 (in Japanese).
11. Hirao M, Hashimoto J, Ando W, Ono T, Yoshikawa H. Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women. J Bone Miner Metab. 2008;26:260-4.
12. Nakayama H, Hagiwara F, Tohma S. Three-year effects of bisphosphonates on treatment of osteoporosis and on reducing the risk for vertebral fractures of rheumatoid arthritis patients. Osteoporos Japan. 2007;15:13-8.
13. Iwamoto J, Takeda T, Ichimura S. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J Orthop Sci. 2000;5:546-51.
14. Knapen MH, Schurgers LJ, Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int. 2007;18:963-72.